Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 305-312

  Couderc, Thérèse ^a   Delpeyroux, Francis ^a   Blay, Hélène L E ^a   Blondel, Bruno ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RECEPTOR; VIRUS RNA;

ADAPTATION; ANIMAL CELL; ARTICLE; CELL LINE; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; INTERNALIZATION; MOUSE; NONHUMAN; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; RNA TRANSPORT; THERMOSTABILITY; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS PARTICLE; VIRUS VIRULENCE;

ADAPTATION, PHYSIOLOGICAL; ANIMAL; BINDING SITES; CAPSID; CAPSID PROTEINS; DEFECTIVE VIRUSES; HEAT; HELA CELLS; HUMAN; MICE; MUTATION; POLIOVIRUS; RNA, VIRAL; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; VIRUS ASSEMBLY;

EID: 0029656107     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.305-312.1996     Document Type: Article

References (41)

1. Barnert, R. H., H. Zeichhardt, and K. O. Habermehl. 1992. Identification of 50-kDa and 23-/25-kDa HeLa cell membrane glycoproteins involved in poliovirus infection - occurrence of poliovirus specific binding sites on susceptible and nonsusceptible cells. Virology 186:533-542.
2. Blondel, B., R. Crainic, O. Fichot, G. Dufraisse, A. Candrea, M. Girard, and F. Horaud. 1986. Mutations conferring resistance to neutralization with monoclonal antibodies m type 1 poliovirus can be located outside or inside the antibody-binding site. J Virol. 57:81-90.
3. Blondel, B., O. Akacem, R. Crainic, P. Couillin, and F. Horodniceanu. 1983. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat inactivated virions. Virology 126:707-710
4. Colonno, R. J., J. H. Condra, S. Mizutani, P. L. Callahan, M. E. Davies, and M. A. Murcko. 1988. Evidence for the direct involvement of the rhinovirus canyon in receptor binding. Proc. Nail Acad. Sci. USA 85:5449-5453.
5. Colston, E., and V. R. Racaniello. 1994 Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor EMBO J 13:5855-5862.
6. Colston, E. M., and V. R. Racaniello. 1995. Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J. Virol. 69:4823-4829.
7. Couderc, T., T. Barzu, F. Horaud, and R. Crainic. 1990 Poliovirus permissivity and specific receptor expression on human endothelial cells. Virology 174:95-102.
8. Couderc, T., N. Guédo, V. Calvez, I. Pelletier, J. Hogle, F. Colbère-Garapin, and B. Blondel. 1994. Substitutions in the capsids of poliovirus mutants selected in human neuroblastonia cells confer on the Mahoney type 1 strain a phenotype neurovirulent in mice. J. Virol 68:8386-8391
9. Couderc, T., J. Hogle, H. Le Blay, F. Horaud. and B. Blondel. 1993 Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell. J Virol. 67:3808-3817
10. Dietzschold, B., T. J. Wiktor, J. Q. Trojanowski, R. I. Macfarlan, W. H. Wunner, M. J. Torres-Anjel, and H. Koprowski. 1985. Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J. Virol. 56:12-18
11. Everaert, L., R. Vrijsen, and A. Boeyé. 1989. Eclipse products of poliovirus after cold-synchronized infection of HeLa cells. Virology 171:76-82.
12. Fenwick, M. L., and P. D. Cooper. 1962. Early interactions between poliovirus and ERK cells. Some observations on the nature and significance of the rejected particles. Virology 18:212 223.
13. Filman, U. J., R. Syed, M. Chow, A. J. Macadam, P. D. Minor, and J. M. Hogle. 1989. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus EMBO J. 8:1567-1579
14. Flore, O., C. E. Fricks, D. J. Filman, and J. M. Hogle. 1990 Conformational changes in poliovirus assembly and cell entry, p 429-438. In J M. Hogle (ed) Seminars in virology. W. B. Saunders Co., London.
15. Fricks, C. E., and J. M. Hogle. 1990. Cell-induced conformational change in poliovirus. externalization of the ammo terminus of VP1 is responsible for liposome binding. J. Virol. 64:1934-1945.
16. Gomez Yafal, A., G. Kaplan, V. R. Racaniello, and J. M. Hogle. 1993. Characterization of poliovirus conformational alteration mediated by soluble receptors. Virology 197:501-505.
17. Hogle, J. M., M. Chow, and D. J. Filman. 1985 Three dimensional structure of poliovirus at 2 9 Å resolution Science 229:1358-1365.
18. Holland. J. J. 1961. Receptor affinities as major determinants of enterovirus tissue tropisms in humans. Virology 15:312-326.
19. Joklik, W. K., and J. E. Darnell. 1961 The adsorption and early fate of purified poliovirus in HeLa cells Virology 13:439-147.
20. Kaplan, G., M. S. Freistadt, and V. R. Racaniello. 1990 Neutralization of poliovirus by cell receptors expressed in insect cells. J. Virol 64:4697-4702
21. Kirkegaard, K. 1990 Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J. Virol. 64:195-206.
22. Koike, S., H. Horie, I. Ise, A. Okitsu, M. Yoshida, N. Iizuka, K. Takeuchi, T. Takegami, and A. Nomoto. 1990 The poliovirus receptor protein is produced both as membrane-bound and secreted forms EMBO J. 9:3217-3224
23. Koike, S., C. Taya, T. Kurata, S. Abe, I. Ise, H. Yonekawa, and A. Nomoto. 1991. Transgenic mice susceptible to poliovirus. Proc Natl. Acad. Sci. USA 88:951-955.
24. Lonberg-Holm, K. L., L. B. Gosser, and J. J. Kauer. 1975. Early alteration of poliovirus in intected cells and its specific inhibition J Gen Virol. 27:329-342
25. Lonberg-Holm, K. L., L. B. Gosser, and E. J. Shimshick, 1976 Interaction of liposomes with subviral particles of poliovirus type 2 and rhinovirus type 2. J. Virol. 19:746-749.
26. pro. J. Virol 68:7507-7515
27. Martin, A., C. Wychowski, T. Couderc, R. Crainic, J. Hogle, and M. Girard. 1988. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimeric virus which is neurovirulent for mice. EMBO J 7:2839-2847.
28. Mason, P. W., B. Baxt, F. Brown, J. Harber, A. Murdin, and E. Wimmer. 1993. Antibody-complexed foot-and-mouth disease virus, but not poliovirus, can infect normally insusceptible cells via the Fc receptor. Virology 192:568-577.
29. Melnick, J. L., H. A. Wenner, and C. A. Philips. 1979. Enteroviruses, p 471-534 In E. H. Lennette and N. J Schmidt (ed.), Diagnostic procedure for viral, rickettsial and chlamydial infections. American Public Health Association, Washington, D.C.
30. Mendelsohn, C., B. Johnson, K. A. Lionetti, P. Nobis, E. Wimmer, and V. R. Racaniello. 1986. Transformation of a human poliovirus receptor gene into mouse cells. Proc. Natl. Acad. Sci. USA 83:7845-7849.
31. Mendelsohn, C. L., E. Wimmer, and V. R. Racaniello. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily Cell 56:855-865.
32. Morrison, M. E., and V. R. Racaniello. 1992. Molecular cloning and expression of a murine homolog of the human poliovirus receptor gene. J. Virol 66:2807-2813.
33. Moscufo, N. A., A. Gomez Yafal, A. Rogove, J. M. Hogle, and M. Chow. 1993. A mutation in VP4 defines a new, step in the late stages of cell entry by poliovirus. I. Virol. 67:5075-5078.
34. Moss, E. G., and V. R. Racaniello. 1991. Host range determinants located on the interior of the poliovirus capsid EMBO J. 10:1067-1074.
35. Mosser, A. G., and R. R. Rueckert. 1993. WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present. J. Virol. 67:1246-1254.
36. Mosser, A. G., J. Y. Sgro, and R. R. Rueckert. 1994. Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions. J. Virol. 68:8193-8201.
37. Murray, M. G., J. Bradley, X. F. Yang, E. Wimmer, E. G. Moss, and V. R. Racaniello. 1988. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science 241:213-215.
38. Olson, N. H., P. R. Kolatkar, M. A. Oliveira, R. H. Cheng, J. M. Greve, A. McClelland, T. S. Baker, and M. G. Rossmann. 1993. Structure of a human rhinovirus complexed with its receptor molecule. Proc. Natl. Acad Sci. USA 90:507-511.
39. Ren, R. B., F. Costantini, E. J. Gorgacz, J. J. Lee, and V. R. Racaniello. 1990. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell 63:353-362.
40. Rueckert, R. R. 1976. On the structure and morphogenesis of picornaviruscs, p 131-213. In H. Fraenkel-Comat and R Wagner (ed.). Comprehensive virology Plenum Press. N Y
41. Shepley, M. P., and V. R. Racaniello. 1994. A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44. J. Virol 68:1301-1308.